Odunsi K - Search Results

1

A phase I trial of intraperitoneal GEN-1, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer, administered with pegylated liposomal doxorubicin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancers: An NRG Oncology/Gynecologic Oncology Group study.

Thaker PH, Brady WE, Lankes HA, Odunsi K, Bradley WH, Moore KN, Muller CY, Anwer K, Schilder RJ, Alvarez RD, Fracasso PM. Thaker PH, et al. Among authors: odunsi k. Gynecol Oncol. 2017 Nov;147(2):283-290. doi: 10.1016/j.ygyno.2017.08.001. Epub 2017 Aug 10. Gynecol Oncol. 2017. PMID: 28802766 Free PMC article. Clinical Trial.

2

Evaluation of prognostic factors and treatment modalities in ovarian cancer patients with brain metastases.

Anupol N, Ghamande S, Odunsi K, Driscoll D, Lele S. Anupol N, et al. Among authors: odunsi k. Gynecol Oncol. 2002 Jun;85(3):487-92. doi: 10.1006/gyno.2002.6653. Gynecol Oncol. 2002. PMID: 12051879

3

Weekly paclitaxel in patients with recurrent or persistent advanced ovarian cancer.

Ghamande S, Lele S, Marchetti D, Baker T, Odunsi K. Ghamande S, et al. Among authors: odunsi k. Int J Gynecol Cancer. 2003 Mar-Apr;13(2):142-7. doi: 10.1046/j.1525-1438.2003.13045.x. Int J Gynecol Cancer. 2003. PMID: 12657114 Clinical Trial.

4

Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.

Olawaiye A, Caesar L, Walsh D, Lyman M, Yeh J, Rodabaugh K, Marchetti D, Lele S, Odunsi K. Olawaiye A, et al. Among authors: odunsi k. Gynecol Oncol. 2004 Sep;94(3):796-802. doi: 10.1016/j.ygyno.2004.06.031. Gynecol Oncol. 2004. PMID: 15350375

5

Response of combination platinum and gemcitabine chemotherapy for recurrent epithelial ovarian carcinoma.

Villella J, Marchetti D, Odunsi K, Rodabaugh K, Driscoll DL, Lele S. Villella J, et al. Among authors: odunsi k. Gynecol Oncol. 2004 Dec;95(3):539-45. doi: 10.1016/j.ygyno.2004.07.056. Gynecol Oncol. 2004. PMID: 15581960

6

Targeted therapy for epithelial ovarian cancer.

Sharma S, Odunsi K. Sharma S, et al. Among authors: odunsi k. Expert Opin Ther Targets. 2005 Jun;9(3):501-13. doi: 10.1517/14728222.9.3.501. Expert Opin Ther Targets. 2005. PMID: 15948670 Review.

7

A-kinase anchoring protein 3 messenger RNA expression correlates with poor prognosis in epithelial ovarian cancer.

Sharma S, Qian F, Keitz B, Driscoll D, Scanlan MJ, Skipper J, Rodabaugh K, Lele S, Old LJ, Odunsi K. Sharma S, et al. Among authors: odunsi k. Gynecol Oncol. 2005 Oct;99(1):183-8. doi: 10.1016/j.ygyno.2005.06.006. Gynecol Oncol. 2005. PMID: 16005946

8

Expression of Wilms tumor gene (WT1) in epithelial ovarian cancer.

Hylander B, Repasky E, Shrikant P, Intengan M, Beck A, Driscoll D, Singhal P, Lele S, Odunsi K. Hylander B, et al. Among authors: odunsi k. Gynecol Oncol. 2006 Apr;101(1):12-7. doi: 10.1016/j.ygyno.2005.09.052. Epub 2005 Nov 2. Gynecol Oncol. 2006. PMID: 16263157

9

Primary fallopian tube carcinoma: a retrospective clinicopathologic study.

Singhal P, Odunsi K, Rodabaugh K, Driscoll D, Lele S. Singhal P, et al. Among authors: odunsi k. Eur J Gynaecol Oncol. 2006;27(1):16-8. Eur J Gynaecol Oncol. 2006. PMID: 16550961

10

Characterization of neutropenic fever in patients receiving first-line adjuvant chemotherapy for epithelial ovarian cancer.

Sharma S, Rezai K, Driscoll D, Odunsi K, Lele S. Sharma S, et al. Among authors: odunsi k. Gynecol Oncol. 2006 Oct;103(1):181-5. doi: 10.1016/j.ygyno.2006.02.012. Epub 2006 Mar 30. Gynecol Oncol. 2006. PMID: 16574203

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters